In addition to LAL-D, LAL may also play a role in the development of non-alcoholic fatty liver disease (NAFLD) and has been proposed as a potential blood biomarker of NAFLD severity (10, 11). This evidence concerns the gene LIPA and metabolic dysfunction-associated steatotic liver disease.